Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP

Updated on: January 20,2025

Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP

Updated on:January 20,2025

Microscopic cell changes linked to cancer's rapid growth in stiff tissues

by Bailey Noah,Texas A&M UniversityResearchers in the Lele Lab analyzing cell imaging data. Credit: Texas A&M EngineeringIn 2022 alone, over 20 million people were diagnosed with cancer,

Updated on: January 21,2025

Microscopic cell changes linked to cancer's rapid growth in stiff tissues

by Bailey Noah,Texas A&M UniversityResearchers in the Lele Lab analyzing cell imaging data. Credit: Texas A&M EngineeringIn 2022 alone, over 20 million people were diagnosed with cancer,

Updated on:January 21,2025

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on: January 21,2025

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on:January 21,2025

New treatment target for neuroendocrine prostate cancer discovered

by Roswell Park Comprehensive Cancer CenterMitochondria are dysfunctional in neuroendocrine prostate tumors. Credit:Oncogene(2024). DOI: 10.1038/s41388-024-03261-4A team of researchers at

Updated on: January 22,2025

New treatment target for neuroendocrine prostate cancer discovered

by Roswell Park Comprehensive Cancer CenterMitochondria are dysfunctional in neuroendocrine prostate tumors. Credit:Oncogene(2024). DOI: 10.1038/s41388-024-03261-4A team of researchers at

Updated on:January 22,2025

Changes in blood cell production over the lifetime could impact leukemia outcomes

by Susanne Clara Bard,University of California - San DiegoCredit: Unsplash/CC0 Public DomainResearchers at University of California San Diego School of Medicine and their colleagues have develop

Updated on: December 21,2024

Changes in blood cell production over the lifetime could impact leukemia outcomes

by Susanne Clara Bard,University of California - San DiegoCredit: Unsplash/CC0 Public DomainResearchers at University of California San Diego School of Medicine and their colleagues have develop

Updated on:December 21,2024

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on: January 17,2025

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on:January 17,2025

Breast cancer treatment advances with light-activated 'smart bomb'

Updated on: March 25,2025

Breast cancer treatment advances with light-activated 'smart bomb'

Updated on:March 25,2025

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on: January 21,2025

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on:January 21,2025

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence

Updated on: December 20,2024

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence

Updated on:December 20,2024

Highly invasive tumor hijacks neurons to grow, but a common heart medication offers hope

byChinese Academy of SciencesMouse craniopharyngioma. Credit: IGDBChinese researchers have revealed new insights into the growth of craniopharyngioma and identified a potential therapeutic treat

Updated on: January 21,2025

Highly invasive tumor hijacks neurons to grow, but a common heart medication offers hope

byChinese Academy of SciencesMouse craniopharyngioma. Credit: IGDBChinese researchers have revealed new insights into the growth of craniopharyngioma and identified a potential therapeutic treat

Updated on:January 21,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on: January 23,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on:January 23,2025

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on: December 21,2024

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on:December 21,2024